For media inquiries
[email protected]
News & Insights.
Find out how Ori is driving innovation in cell & gene manufacturing, via our latest press releases, media coverage and industry insights
Press Release
Ori Biotech’s IRO® Platform Receives FDA Advanced Manufacturing Technology (AMT) Designation
AMT designation provides developers using IRO with earlier and more frequent FDA engagement, accelerating regulatory filings and patient access.
Read more
Trends |
Patient Access Tracker
Updated July 2025 – Ori has calculated the number of patients treated with commercially available cell therapies
Read more
Press Releases
View Ori’s latest press releases to stay up to date with Ori’s scientific, partnership and commercial announcements
Press Release
Ori Biotech Partners with Seattle Children’s Research Institute to Advance Cell Therapy Manufacturing
Seattle Children’s Research Institute becomes the 13th partner actively using …
Read more
Press Release
MaxCyte and Ori Biotech Collaborate to Improve Manufacturing Efficiencies and Broaden Adoption of Autologous Cellular Therapies
MaxCyte and Ori Biotech successfully integrate their ExPERT™ and IRO® …
Read more
Press Release
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
March 18, 2025 – Preferred Partner Network (PPN) members will …
Read more
